Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 22Thoracic 1Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Lymphoid 1Head & Neck 1Gynecologic 1Genitourinary 1Dermatologic 1CNS 1Breast 1

Conditions

Prostatic Neoplasms 2Pancreatic Neoplasms 2Neoplasm Metastasis 2Multiple Myeloma 2Melanoma 2Glioblastoma 2Colorectal Neoplasms 2Colonic Neoplasms 2Thyroid Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Rectal Neoplasms 1Neoplasms 1Liver Neoplasms 1Hematologic Neoplasms 1Glioma 1Gallbladder Neoplasms 1Esthesioneuroblastoma, Olfactory 1Endometrial Neoplasms 1Desmoid Tumors 1Craniopharyngioma 1Childhood Central Nervous System Choriocarcinoma 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Adenomatous Polyposis Coli 1

Interventions

Oxaliplatin 2Nivolumab 2Leucovorin 2Irinotecan 2tipifarnib 1entinostat 1Trastuzumab 1Thalidomide 1Temozolomide 1Specimen Handling 1Magnetic Resonance Spectroscopy 1Ipilimumab 1Gemcitabine 1Fluorouracil 1Floxuridine 1Fentanyl 1Erlotinib Hydrochloride 1Docetaxel 1Cisplatin 1Cetuximab 1Capecitabine 1Cannabidiol 1CTLA-4 Antigen 1Bortezomib 1Bevacizumab 1Bariatric Surgery 17-hydroxystaurosporine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gallbladder Neoplasms × Fluorouracil × CNS × Clear all
NCT03607643 2018-07-31

A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies

Leaf Vertical Inc.

Phase 1/2 Unknown
160 enrolled
CNSGastrointestinalPlasma cell

Colonic Neoplasms, Gallbladder Neoplasms, Glioblastoma, Liver Neoplasms, Multiple Myeloma, Pancreatic Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡